Global Smoking Cessation and Nicotine De-Addiction Products Market (Product Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts can be better treated with smoking cessation products. The global market for smoking cessation and nicotine de-addiction products encompasses nicotine replacement therapy (NRT), electronic cigarettes and therapeutic medication such as anti-depressants and nicotine receptor agonists. Government is emphasizing strict regulations to control the nicotine and cigarette addiction due to its toxic effects on cardiac and respiratory systems. The government policies in relation to smoking cessation include smoking prohibition in public places, high taxes on tobacco products and support for smoking discontinuation therapies. Hence, global market for smoking cessation and nicotine de-addiction products is expected to witness high CAGR during the forecast period. Johnson & Johnson, Pfizer, GlaxoSmithKline, Takeda Pharmaceuticals, Revolymer PLC and Cipla are some of the key leaders of this market. NJOY and VMR products are the key players for e-cigarettes market. GlaxoSmithKline and Pfizer are the leaders in drug therapy products market for smoking cessation and nicotine de-addiction.

The global market for smoking cessation and nicotine de-addiction products is segmented based on product types and geography. Based on type of products, the global market is segmented as Nicotine Replacement Therapy Products, Drug Therapy, Nicotine Sublingual Tablets, Nicotine Inhalers and E-cigarettes. Electronic cigarettes (E-cigarettes) dominate the overall market for smoking cessation and nicotine de-addiction. The largest share for E-cigarettes is shared by North America and Europe. Nicotine Gums and Nicotine Transdermal Patches dominate the global market for Nicotine Replacement Therapy Products. Geographically, global market for smoking cessation and nicotine de-addiction products is segmented into North America, Europe, Asia-Pacific and LAMEA. North America rules the global market for smoking cessation and nicotine de-addiction products; whereas, Asia-Pacific is predicted as profitable market in the near future due increased health awareness and government support programs.

KEY BENEFITS

• This report offers the following benefits in particular:
• In-depth coverage of drivers, restraints and opportunities within global market for smoking cessation and nicotine de-addiction products would help professionals to better understand market behavior
• Porter’s Five Forces analysis examines the competitive structure of the global market for smoking cessation and nicotine de-addiction products and would assist market strategists in their respective decision making process
• Pin-point analysis of geographic segments helps to identify opportunities for growth within the global market for smoking cessation and nicotine de-addiction products
• Deep insights to key development and regulatory framework of global market for smoking cessation and nicotine de-addiction products would be informative for professionals in corporate sector   

KEY MARKET SEGMENTS

The global market for smoking cessation and nicotine de-addiction products is segmented into two major categories such as, Product type and geography. 

MARKET BY PRODUCT TYPE

• Nicotine Replacement Therapy Products
  • Nicotine Lozenges
  • Nicotine Gums
  • Nicotine Sprays
  • Nicotine Transdermal Patches
• Drug Therapy
  • Zyban (Bupropion)
  • Chantix (varenicline)
• Nicotine Sublingual Tablets
• Nicotine Inhalers
• E-cigarettes

MARKET BY GEOGRAPHY

• North America
• Europe
• Asia-Pacific
• LAMEA